Browsing by Titles

Showing results 1 to 3 of 3

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

  • Venneti, Sriram ; 
  • Kawakibi, Abed Rahman ; 
  • Ji, Sunjong ; 
  • Waszak, Sebastian M. ; 
  • Sweha, Stefan R. ; 
  • Mota, Mateus ; 
  • Pun, Matthew ; 
  • Deogharkar, Akash ; 
  • Chung, Chan ; 
  • Tarapore, Rohinton S. ; 
  • et al
  • 2023-11
  • Venneti, Sriram. (2023-11). Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways. Cancer Discovery, 13(11), 2370–2393. doi: 10.1158/2159-8290.cd-23-0131
  • American Association for Cancer Research
  • View : 506
  • Download : 195
  • Sweha, Stefan R. ; 
  • Chung, Chan ; 
  • Natarajan, Siva Kumar ; 
  • Panwalkar, Pooja ; 
  • Pun, Matthew ; 
  • Ghali, Amer ; 
  • Bayliss, Jill ; 
  • Pratt, Drew ; 
  • Shankar, Anand ; 
  • Ravikumar, Visweswaran ; 
  • et al
  • 2021-10
  • Sweha, Stefan R. (2021-10). Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas. Science Translational Medicine, 13(615). doi: 10.1126/scitranslmed.abf7860
  • American Association for the Advancement of Science
  • View : 565
  • Download : 0

Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma

  • Mbah, Nneka E. ; 
  • Myers, Amy L. ; 
  • Sajjakulnukit, Peter ; 
  • Chung, Chan ; 
  • Thompson, Joyce K. ; 
  • Hong, Hanna S. ; 
  • Giza, Heather ; 
  • Dang, Derek ; 
  • Nwosu, Zeribe C. ; 
  • Shan, Mengrou ; 
  • et al
  • 2024-10
  • Mbah, Nneka E. (2024-10). Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma. Nature Communications, 15(1). doi: 10.1038/s41467-024-52973-4
  • Nature Publishing Group
  • View : 348
  • Download : 86
1